tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Palvella Therapeutics expects cash to fund operations into H2 of 2027

Cash and cash equivalents of $75.6 million as of March 31, 2025, expected to fund operations into the second half of 2027

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1